Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 9,050.00
+200.00 (2.26%)
At close: Sep 9, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 139.07 billion as of September 9, 2026. Its market cap has decreased by -29.26% in one year.
Market Cap
139.07B
Enterprise Value
117.05B
Revenue
3.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,050.00
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 139.07B, a decrease of -21.65%. That is a compound annual growth rate of -8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 139.07B | -59.99% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 185.94B |
| Genome & Company | 176.25B |
| Bio Solution | 169.28B |
| NIBEC | 169.04B |
| TiumBio | 143.88B |
| Ensol Biosciences | 143.76B |
| ISU Abxis | 140.47B |
| ViGenCell | 138.98B |